TY - JOUR
T1 - Insect venom allergy
T2 - Diagnosis and treatment
AU - Valentine, Martin D.
N1 - Funding Information:
From the Division of Allergy Hopkins University School Hospital, Baltimore, Md. Supported by grant AI 15443.
Funding Information:
This continuing medical education self-assessment is sponsored by The American Academy of Allergy Immunology and supported by a grant-in-aid from Corporation.
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1984/3
Y1 - 1984/3
N2 - Allergy to insect venom is IgE mediated. Untreated, it occasionally terminates fatally and often causes temporary illness. Medical intervention with venom immunotherapy in patients with prior systemic reactions presents reactions to stings by inducing IgG-antibody formation, although in some groups of patients this results in little real benefit. Emergency self-treatment kits, (Epi-Pen and Epi-Pen Jr., Center Laboratories, Port Washington, N.Y.; Ana Kit, Hollister-Stier, Spokane, Wash.) if promptly and intelligently used, may reverse most moderate sting reactions. Some severe reactions require aggressive therapy. Until better treatment criteria are available, the most certain way of reducing the risk of systemic reactions to stings is with venom immunotherapy.
AB - Allergy to insect venom is IgE mediated. Untreated, it occasionally terminates fatally and often causes temporary illness. Medical intervention with venom immunotherapy in patients with prior systemic reactions presents reactions to stings by inducing IgG-antibody formation, although in some groups of patients this results in little real benefit. Emergency self-treatment kits, (Epi-Pen and Epi-Pen Jr., Center Laboratories, Port Washington, N.Y.; Ana Kit, Hollister-Stier, Spokane, Wash.) if promptly and intelligently used, may reverse most moderate sting reactions. Some severe reactions require aggressive therapy. Until better treatment criteria are available, the most certain way of reducing the risk of systemic reactions to stings is with venom immunotherapy.
UR - http://www.scopus.com/inward/record.url?scp=0021344198&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021344198&partnerID=8YFLogxK
U2 - 10.1016/0091-6749(84)90397-X
DO - 10.1016/0091-6749(84)90397-X
M3 - Article
C2 - 6366028
AN - SCOPUS:0021344198
SN - 0091-6749
VL - 73
SP - 299
EP - 304
JO - The Journal of allergy and clinical immunology
JF - The Journal of allergy and clinical immunology
IS - 3
ER -